chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Fever; Chills; injection site pain; body aches; back pain; jaw and teeth pain; jaw and teeth pain; headache; This is a spontaneous report from a contactable Nurse (patient herself). A 48-years-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number: en6202, expiry date: unknown) via intramuscular route, administered in left arm, on 26Feb2021 09:00 (age at vaccination: 48-years) as dose 2, single for Covid-19 immunisation. Patient was not pregnant at the time of vaccination. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number: el9269, expiry date: unknown) via intramuscular route, administered in right arm, on 05Feb2021 9:00 AM (age at vaccination: 48-years) as dose 1, single for Covid-19 immunisation. Facility type vaccine was other. No other vaccine in four weeks was administered. Medical history of patient included chronic mood disorder, elevated cholesterol, obesity from an unspecified date and unknown if ongoing (other medical history: Chronic mood disorder, elevated cholesterol, obesity). Concomitant medications included Citalopram, Atorvastatin taken in two weeks, taken for unspecified indication, start and stop date unknown. Past drug event included known allergies due to Bactrim. Patient was not diagnosed for covid prior vaccination and was not tested for covid post vaccination. On 26Feb2021 07:30 PM, patient experienced fever, chills, injection site pain, headache, body aches, back pain, jaw and teeth pain. No treatment was given as a result of the adverse events. The outcome of the events was recovering.    No follow-up attempts are Possible. Information on Lot/batch number cannot be obtained.
Flushed face. Feeling hot. General feeling of exhaustion. Headache. All s/s gone by 6 p.m.
Within 12-48 hrs I experienced the following ailments. I am not a Dr. I do not know which are from the vaccine and which may be from childbirth. Additionally this list only covers things I was not experiencing immediately prior to vaccination or were unique to the situation: -ringing in ears -blurred vision -headache (not migraine) -severely swollen feet -congestion/respiratory problems -itching all over body -eczema/acne -raised white spots on lips -burning sensation in feet (peripheral nerve damage) -jaw/neck/throat pain Vaccines were given after delivering my child. Easy pregnancy. Full term child. Was induced a couple days early due to my blood pressure being a little high and because my dr said she would be out of town on his due date. Was GBS positive and given antibiotics during labor. Epidural catheter was placed 3 times but test dose was ineffective. There was no time for pain medication during delivery. An hr or less after he was born I was walking around (with escorts) and then moved to a new room. Everything was fine. When it was time to leave it was strongly suggested I be vaccinated for Pneumonia, TDap, and Flu. I fought with them and 100% denied the Flu vaccine as both times in the past I took it I was diagnosed with the flu within 24-48 hrs following. I allowed the Pneumococcal vaccine. I DO NOT know which manufacturer it was. I also allowed the TDaP vaccine. I was told they were very important due to my history of asthma and since I was breast feeding to pass immunity to my son. The nurse still showed up with and almost gave me the flu vaccine even though I did not sign for it. I had to send her out to recheck which ones I'd agreed to.
Chest pressure, elevated BP, mild SOB 1d after vaccine in pt w/ h/o CP and recent neg cardiac w/u.
Multiple myeloma; This is a spontaneous report received from contactable reporter(s) (Physician) from a sales representative.  A patient (no qualifiers provided) received COVID-19 Vaccine - Manufacturer Unknown, (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation; pneumococcal 13-val conj vac (dipht crm197 protein) (MANUFACTURER UNKNOWN) (Batch/Lot number: unknown) as dose number unknown, single for immunisation; varicella zoster vaccine (MANUFACTURER UNKNOWN) (Batch/Lot number: unknown). The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PLASMA CELL MYELOMA (medically significant), outcome "unknown", described as "Multiple myeloma". The physician stated that this was reported during a conversation that patient received vaccines at local pharmacies, including Covid vaccine, pneumococcal vaccine, and perhaps shingles vaccine, and patients subsequently were diagnosed with multiple myeloma. The reporter did not know whether any of the vaccines were Pfizer products and did not have much information available but wanted to report because the doctor expressed concern regarding administration of concomitant vaccines.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: The event plasma cell myeloma is assessed as likely an intercurrent condition that is unrelated to the use of BNT162B2 and pneumococcal 13-val conjugate vaccine. This assessment will be updated should additional information become available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.,Linked Report(s) : US-PFIZER INC-202200239390 same reporter/drug/event, different patient
Dizziness; This is a spontaneous report from a contactable consumer (patient). A 78-years-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Left on 02Apr2021 14:10 (Lot number FR8733 or ER8733) as SINGLE DOSE for covid-19 immunization. Medical history included ongoing High cholesterol, ongoing COPD, ongoing to help his blood circulation. Prior Vaccinations (within 4 weeks) was None. The patient received first dose of bnt162b2 (lot number: EN6199 or FN6199) on 05Mar2021 14:10 Intramuscular in left arm for COVID-19 Immunization. Concomitant medication(s) included atorvastatin taken for High cholesterol from an unspecified start date (for years) and ongoing; budesonide, formoterol fumarate (SYMBICORT) taken for chronic obstructive pulmonary disease from an unspecified start date (for about a year, maybe more than that) and ongoing; acetylsalicylic acid (BABY ASPIRIN) taken To help his Blood circulation from an unspecified start date (for at least 10 years) and ongoing. The patient experienced dizziness on 04Apr2021 after his second Pfizer COVID-19 vaccination shot and it has lasted approximately 7-8 days. The event did not require a visit to Emergency Room or Physician Office. The outcome was not recovered.  No follow-up attempts are needed. No further information is expected.
At about 2:35pm, 15 minutes post vaccination, patient was seated and leaned forward.  She did not lose consciousness, but appeared pale.  She stated she felt weak and dizzy.  A cot and privacy was provided for patient.  Patient states she did not eat or drink that morning so 8 ounces of juice was provided along with a cereal bar.  Oxygen saturation remained WNL at this time and throughout the episode.  At 2:40pm BP was 145/82.  2:44pm = 142/86.  2:46 = 148/84.  2:47pm = sat up on edge of cot.  2:55pm = 142/94.  2:57 = standing.  Patient walked around at 3:00pm.  HR remained WNL throughout the entire episode.  Patient refused hospital/ambulance transfer.  3:05 = patient states she feels well enough to drive home.  Patient refused help with transportation.  5:00pm on March 19 (same day), writer called patient for follow up.  Patient states she feels better but still some feelings of dizziness and weakness.  Patient was advised to reach out to her PCP for his or her awareness and/or recommendations.  Patient was also advised if symptoms progress to call PCP office for triage or head to ER if necessary.  Follow up call was placed on 3/23/21 at 10:30am.  Patient states she felt weak and dizzy throughout the weekend and Monday, but states today she is at baseline.
pregnancy; after first dose, her arm was sore; This spontaneous prospective pregnancy case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (pregnancy) and VACCINATION SITE PAIN (after first dose, her arm was sore) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039K20A and 028L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history). Concomitant products included PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS FUMARATE;FOLIC ACID;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL ACETATE;RIBOFLAVIN;THIAMINE MONONITRATE;TOCOPHERYL ACETATE;ZINC OXIDE].   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 01-Oct-2021. On an unknown date, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (pregnancy) and VACCINATION SITE PAIN (after first dose, her arm was sore). At the time of the report, MATERNAL EXPOSURE DURING PREGNANCY (pregnancy) had resolved and VACCINATION SITE PAIN (after first dose, her arm was sore) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not reported. Treatment information was not provided.; Reporter's Comments: This is a case of product exposure during pregnancy with associated non-serious adverse events of soreness of arm, chills and low grade temperature for this 29-year-old female. Patient will continue to be contacted for further monitoring of AEs during the pregnancy.
Left thigh with 3x2 cm area induration, warm with 4x6 round area of redness. Prescribed KEFLEX 250mg/ml 8ml po every 6 hours for 10 days. MOTRIN as needed for pain or fever.
Came down with cold symptoms on 09/22/2022. Took a Home COVID-19 test and it was positive. Was prescribed Paxlovid.
Numbness in my face and lips, predominantly on my right side but a little bit on my left side; Numbness in my lips, predominantly on my right side but a little bit on my left side; Red blotch at the injection site and 5days later turned into a bull's eye; Large welt immediately after the shot, at the injection site / Red blotch at the injection site; Red blotch at the injection site and 5days later turned into a bull's eye; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Numbness in my face and lips, predominantly on my right side but a little bit on my left side), HYPOAESTHESIA ORAL (Numbness in my lips, predominantly on my right side but a little bit on my left side), RASH MACULAR (Red blotch at the injection site and 5days later turned into a bull's eye), VACCINATION SITE URTICARIA (Large welt immediately after the shot, at the injection site / Red blotch at the injection site) and VACCINATION SITE ERYTHEMA (Red blotch at the injection site and 5days later turned into a bull's eye) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     Concomitant products included METOPROLOL for an unknown indication.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced HYPOAESTHESIA (Numbness in my face and lips, predominantly on my right side but a little bit on my left side), HYPOAESTHESIA ORAL (Numbness in my lips, predominantly on my right side but a little bit on my left side), RASH MACULAR (Red blotch at the injection site and 5days later turned into a bull's eye), VACCINATION SITE URTICARIA (Large welt immediately after the shot, at the injection site / Red blotch at the injection site) and VACCINATION SITE ERYTHEMA (Red blotch at the injection site and 5days later turned into a bull's eye). In January 2021, HYPOAESTHESIA (Numbness in my face and lips, predominantly on my right side but a little bit on my left side), HYPOAESTHESIA ORAL (Numbness in my lips, predominantly on my right side but a little bit on my left side) and VACCINATION SITE URTICARIA (Large welt immediately after the shot, at the injection site / Red blotch at the injection site) had resolved. At the time of the report, RASH MACULAR (Red blotch at the injection site and 5days later turned into a bull's eye) outcome was unknown and VACCINATION SITE ERYTHEMA (Red blotch at the injection site and 5days later turned into a bull's eye) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment was provided for the events.
Less than 24 hrs, pt had red, raised, rash to face, neck, behind ears. Mother, placed CORTAIDE topical ointment until 12/21/10.
Approximately one hour after vaccination parent reports child's eyes appeared puffy.  Progression to red rash on arms, face, and legs by 10:30am 1/13/2010.  No fever.  Child seen in Hospital and given prednisone + Benadryl.  Consultation with pediatrician 1/13/2010 as well - treatment continues as of 1/15/2010.  Parent also reports hyperactivity, which is unusual, but otherwise child is not acting ill or in pain.
Onset increased muscle pain, fatigue, weakness, dysphagia, weight loss. Pt requiring Prednisone IVIG every q monthly. Methotrexate headache, muscle atrophy. 2/6/09 Received PCP medical records of 11/11/08-1/20/09. FINAL DX: polymyositis, likely MCV4 vaccine related; osteomalacia; neuropathy; pernicious anemia; tachycardia; ataxia; Budd-Chiari syndrome; dermatomyositis. Records reveal patient experienced muscle weakness, paresthesias, leg pain.  Referred to Neuro & Rheum.  Tx w/PT & meds including methotrexate, imuran, steroids, enbrel, bicillin, IVGG.  Had to drop out of college due to illness. 04/6/2010 Patient's condition never improved and she died on 3/23/2009.
SHIVERS, FEVER, at 10 pm on 10/17/20. took Advil which didn't seem to help. Took  Tylenol that helped. Shivers, fever again at 7:45 pm on 10/18/20. Took tylenol.
Systemic: Confusion-Severe, Systemic: Dizziness / Lightheadness-Severe, Systemic: Fainting / Unresponsive-Severe, Additional Details: pt got pfizer covid shot  on left arm and fluzone on right  felt light headed and dizzy fainted fell and hit his chin and was unresponsive for a few minutes paramedics came to check pt out was fine
This spontaneous report was received from a pharmacist referring to a patient of unknown age and gender. No concurrent or historical condition were reported. On 22-JAN-2015 the patient was vaccinated with the first dose of ZOSTAVAX (Lot number and expiration date not provided) dose, route, anatomical location were unknown, and a second dose of ZOSTAVAX (Lot number and expiration date not provided) dose, route, anatomical location were unknown, was inadvertently administered on 01-SEP-2015. No adverse effects were reported. No further information was provided. Additional information has been requested.
Swelling of injections site, hot and chills, stiffness in left side of neck
Information has been received from a healthcare worker concerning an unspecified number of patients of unknown age and gender. Patients' concomitant medication, pertinent medical history and drug reactions/allergies were not reported. On unknown dates the patients were vaccinated with unspecified improperly stored doses of (Merck) VARIVAX (dose, unit and route not reported, Lot # L031066 with Exp. date 18-AUG-2017, Lot# L034367 with Exp. date 08-SEP-2017 and Lot# L020000 with Exp. date 02-JUN-2017). The vaccinates were exposed to 24.3 F for 2 hours 43 minutes. There was previous temperature excursion reported. For vaccinates with Lot# L031066, they had been exposed to 36.7 F for 18 hours 25 minutes or 21 hours 8 minutes in total. For vaccinates with Lot# L020000and Lot# L034367, they had been exposed to 36.7 F for 13 hours. No adverse effects were reported. Additional information has been requested.
3 days, post vax, child broke out in chickenpox and ER doctor dx'd chickenpox.
This spontaneous consumer report (initial receipt 26-Sep-2013) concerns a female patient of unknown age. The patient's concurrent condition included osteoporosis. The patient's past medications included alendronic acid (70 mg, tablet) which had 'bothered her stomach a little'. At an unspecified time, the patient commenced high blood pressure medications which had caused some acid indigestion (including losartan which had caused an upset stomach). After a long time, she discontinued alendronic acid. On an unspecified date, the patient received a flu shot (manufacturer and batch number not reported) as the patient had osteoporosis. The 'flu shot did not contain the necessary active ingredient to combat the flu strain that was prevalent at that time'. On an unspecified date (in 2008), approximately three years after ceasing alendronic acid, the patient caught the flu. She became very ill and was hospitalised for 10 days on life support. The patient was put on life support system with the tube down her esophagus and was told that she would have difficulty in swallowing. The patient had stopped taking alendronic acid approximately three years before she caught the flu, therefore there was 'no possibility that alendronic acid could have caused the illness'. The patient was told to start taking alendronic acid because her osteoporosis was getting worse. No laboratory tests were reported. Outcome was not reported.
I remember right after the shot, during the 15 minutes I had to sit and wait before leaving the vaccine location, I asked my husband if it itched where he got the shot.  His did not and for me it only lasted a minute or so.  It did not itch when we left.  About 4 hours later, I noticed my arm was red around the injection site, probably a 1 inch diameter.  It was very warm, sore to the touch and hard.  The next morning, the redness had spread to a n oval shape and was about 3 inches long and 2" tall.  It is now  60 hours since getting the shot and it is still sore, hard, but not is red, although still visible.  It has itched some but not constant itching.
Patient showed me a picture of her arm the night after the shot. It was a bit swollen with some red patches from her shoulder down the arm to the elbow. She said it was swollen, hot, red, and painful. She did not touch it because it was painful even without contact. The reaction started noticeably the night after the shot and lasted at least 3 days.
Systemic: Dizziness / Lightheadness-Mild, Additional Details: patient indicated slight dizziness post vaccination, questioned pateint on feeling nervous, patient indicted that he felt slighly anxious and did not eat all day, gave patient Gatorade, and had him lay down. Patinetts dizzinies resolved after few minutes, and drinking Gatorade. Asked patient if he wanted an ambulance, he indicated that he was feeling normal and did not want an ambulance. Follow up call with patient at end of my shift, patinet indicated that he had a meal and felt perfectly fine.
crying persistent & inconsolable x 6 hrs; low grade temp; swelling of thigh twice the nl diameter that visual redness 24 hrs induration around inject site approx 4 cm in size;
Discharge Provider: MD Primary Care Provider: MD Admission Date: 6/2/2022 Discharge Date: Jun 9, 2022  PRESENTING PROBLEM: Chronic obstructive pulmonary disease with acute exacerbation (HCC) [J44.1] COVID-19 [U07.1]   HOSPITAL COURSE: The patient is a 61 year old male with PMH of COPD, HTN, CAD, DM2, and BPH. He presented to the ED due to worsening dyspnea and found to be COVID-19 positive. In the ED, he was noted to by hypoxic and therefore admitted to the medicine service of acute hypoxic respiratory failure secondary to COVID-19 PNA   #acute hypoxemic respiratory failure  #COVID-19 PNA  #haemophilus influenza in sputum #non-oxygen dependent COPD with exacerbation Patient was noted to be vaccinated against COVID-19 with booster given 12/27/2021 and reported symptoms started 5/31/22 with dyspnea and cough. CTA thorax was obtained in the ED at time of admission with no evidence of PE (limited view of subsegmental arteries of LLL), GGO and possible mucus plug. Patient was treated with IV Methylprednisolone due to COPD as well as Remdsivir. He was also treated with scheduled Mucinex. Sputum culture was notable for Haemophilus influenzae and due to history of Penicillin allergy was treated with IV Ceftriaxone, this was switched to cefuroxime at discharge; notably his procalcitonin on admission was negative, suggesting that the bacteria was a colonizer, but it was treated out of an abundance of caution given the clinical picture. patient initially required 4 liters of supplemental oxygen on admission, was able to wean to 2L, was given lasix to help wean. patients only complaint was a cough towards the end of his stay here.   #pulmonary nodules: CTA thorax was notable for RUL and LLL scattered nodules. given extensive tabacco use, patient was advised to have repeat CT chest in 3 months to ensure stability/clearance.    #erythrocytosis:  JAK2 drawn per discussion with heme, okay to d/c as no other work-up needed here plan is for patient to follow-up JAK2 results with PCP outpatient.   patient was cleared for discharge on 6/9. hematology was contacted about his slowly rising hemoglobin, they felt he could have work-up begun here with just a blood draw for JAK2 and then following-up with his PCP. patient sent out on oxygen, a steroid taper, two more days of antibiotics to cover the bacterial component of his infection, and instructions to follow-up with his PCP about multiple concerns. at the time of discharge patient was in good spirits with no objections to discharge. his ionly complaint was a cough. all questions and concerns addressed, all meds and follow-ups reviewed.
FLUSHING AND SWELLING OF FACE.  SENSATION OF FACIAL TIGHTNESS, DRY LIPS, ITCHY FACE.
Swollen lump , red and hot to touch at vaccination site. Mild pain when touching. First noticed about 24 hrs after injection. Peak redness and swollen  about 36 hrs after injection.